跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Symeril - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Symeril
Approved
STANDARD
Symeril
Diamond Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
45d460176e09e46a
Company
Diamond Laboratories Inc.
Type
Standard
Approval Details
Approval Id
45d460176e09e46a
Drug Approval Philippines Name
Symeril
Product Name
Symeril
Registration Number
DRP-7105
Brand Name
Symeril
Generic Name
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
Dosage Form
Tablet
Dosage Strength
325 mg/25 mg/2 mg
Manufacturer
Diamond Laboratories Inc.
Distributor
Rilem Pharma Corp.
Issuance Date
26 May 2022
Expiry Date
26 May 2027
Pharmacologic Category
Analgesic/S Antipyretic/ Sympathomimetic/ Antihistamine (Substituted Alkylamine)
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
45d460176e09e46a
Type
Standard
Back to Philippines FDA Approvals